BamSEC and AlphaSense Join Forces
Learn More

Marker Therapeutics Inc. – Transcripts

NASDAQ: MRKR    
Share price (5/5/26): $1.51    
Market cap (5/5/26): $25.2 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Other Revised 08/26/25 Marker Therapeutics, Inc. - Special Call 08/26/25
Other Revised 05/29/25 Marker Therapeutics, Inc. - Special Call 05/28/25
CY 2023
Other Revised 08/09/23 Marker Therapeutics, Inc. - Special Call 08/09/23
CY 2022
Other Revised 02/16/22 Marker Therapeutics, Inc. - Special Call 02/16/22
CY 2021
Earnings Revised 05/12/21 Marker Therapeutics, Inc., Q1 2021 Earnings Call, May 12, 2021 05/12/21
CY 2020
Earnings Revised 11/09/20 Marker Therapeutics, Inc., Q3 2020 Earnings Call, Nov 09, 2020 11/09/20
Other Revised 06/01/20 Marker Therapeutics, Inc. - Special Call 06/01/20
Earnings Revised 05/11/20 Marker Therapeutics, Inc., Q1 2020 Earnings Call, May 11, 2020 05/11/20
CY 2019
Earnings Revised 04/10/24 Marker Therapeutics, Inc., Q3 2019 Earnings Call, Nov 12, 2019 11/12/19
Other Revised 07/22/19 Marker Therapeutics, Inc. - Special Call 07/22/19
Other Revised 05/16/19 Marker Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-16-2019 10:40 AM 05/16/19
Other Revised 03/28/19 Marker Therapeutics, Inc. - Special Call 03/28/19